Piramal Pharma Ropes In Ajay Devgn For Skin-care Brand Tetmosol

Piramal Pharma on Monday said its consumer products division has roped in Bollywood actor for its flagship brand Tetmosol.

Tetmosol is a medicated skin-care soap used in the treatment and prevention of skin infections.

Piramal Pharma said it is now strengthening the brand offering by introducing Tetmosol Dusting Powder and increasing its media investments subsequently.

"As we enter the next phase of growth, we are excited to work with to promote Tetmosol to our consumers across India and enhance our reach," Piramal Consumer Products Division CEO Nitish Bajaj said in a statement.

Owing to the tropical climate, India has a high incidence of skin infections and, therefore, the company has introduced two new product offerings with Tetmosol Dusting Powder and Tetmosol Plus Cream that caters to all skin infection problems, he added.

Tetmosol has expanded its retail footprint in India to three lakh chemist stores.

Being the preferred doctor prescribed brand for skin infections, Tetmosol hopes to strengthen its position in the medicated soap industry.

Currently, the brand's products include soap bars, dusting powder, and medicinal cream.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

RECENT NEWS

JPMorgan Deploys AI Chatbot To Revolutionize Research And Productivity

JPMorgan has deployed an AI-based research analyst chatbot to enhance productivity among its workforce, with approximate... Read more

Private Equity And Banks: The Complex Web Of Leverage

Private equity has emerged as a significant force in the global financial landscape, driving substantial growth and inve... Read more

Financial Watchdog Highlights Unresolved Vulnerabilities In Shadow Banking Sector

The world’s leading financial stability watchdog has issued a warning about the unresolved vulnerabilities within the ... Read more

JPMorgan And Small Caps Lead Market Rally: A Sign Of Economic Optimism

In a week marked by strong financial performance, JPMorgan Chase & Co. reported a 25% rise in profits, and US small-... Read more

Big Banks Vs. Regional Banks: The Battle For Market Share

The financial industry is a competitive landscape where big banks and regional banks vie for market share. Each type of ... Read more

The Evolution Of Philanthropic Advisory Services In Private Banks

The landscape of philanthropic advisory services provided by private banks has undergone a significant transformation. T... Read more